Dagoc, Ailene M.
HRN: 20-56-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2022
CEFUROXIME 500MG (TAB)
07/17/2022
07/24/2022
ORAL
500mg Tab
Q12
Post OP (Cesarean Section) Empiric De-escalation
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes